Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Covariate-adjusted reference intervals for diagnostic data.

Alex Dmitrienko1

  • 1Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA. dmitrienko_alex@lilly.com

Journal of Biopharmaceutical Statistics
|May 6, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data.

Statistics in medicine·2024
Same author

Overview of modern approaches for identifying and evaluating heterogeneous treatment effects from clinical data.

Clinical trials (London, England)·2023
Same author

Quantitative MRI Biomarkers as Potential Inclusion Body Myositis Clinical Trial Endpoints.

Neurology·2022
Same author

A two-stage adaptive clinical trial design with data-driven subgroup identification at interim analysis.

Pharmaceutical statistics·2022
Same author

Data-Driven Subgroup Identification in Confirmatory Clinical Trials.

Therapeutic innovation & regulatory science·2021
Same author

Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19.

JACC. Clinical electrophysiology·2021
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

Drug developers use reference intervals to analyze clinical trial data. This study presents covariate-adjusted methods for more accurate analysis of extreme diagnostic measurements.

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Medical Diagnostics

Background:

  • Accurate analysis of extreme diagnostic measurements in clinical trials is crucial for drug development.
  • Diagnostic variable distributions are often influenced by covariates, necessitating adjustments for reliable interpretation.
  • Reference intervals are essential for distinguishing typical from atypical measurements.

Purpose of the Study:

  • To present and compare three methods for constructing covariate-adjusted reference intervals for quantitative diagnostic data.
  • To provide algorithms for optimizing quantile estimation procedures in covariate adjustment.
  • To apply these methods to electrocardiographic data analysis.

Main Methods:

  • Global quantile smoothing

Related Experiment Videos

  • Local quantile smoothing
  • Stepwise quantile approximations using recursive partitioning
  • Algorithms for optimizing polynomial approximation degree, bandwidth parameter, and number of strata

    • Main Results:

    • The study details methods for optimizing quantile estimation in covariate-adjusted reference interval construction.
    • Algorithms are presented for selecting key parameters in each smoothing and partitioning approach.
    • The effectiveness of these methods is demonstrated through their application to electrocardiographic data.

    Conclusions:

    • Covariate-adjusted reference intervals are vital for the accurate analysis of extreme diagnostic measurements in clinical trials.
    • The presented methods offer robust approaches for drug developers to interpret diagnostic data.
    • The application to electrocardiographic data highlights the practical utility of these statistical techniques.